ConductScience.org, home

Paper10469752

Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme.

Milas L and 5 others. J Natl Cancer Inst, 1999. Cited by 195 papers, by iCite.

Cite this record

ConductScience Library. Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme. Papers, record 10469752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10469752

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme.
PubMed
Journal
J Natl Cancer Inst
PubMed
Year
1999
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
195
iCite
Relative citation ratio, by iCite
4.88
iCite
Revised in PubMed
2026-01-28
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Milas LL
2Kishi KK
3Hunter NN
4Mason KK
5Masferrer JLJ L
6Tofilon PJP J

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cyclooxygenase InhibitorsMajor topic
IsoenzymesMajor topic
Prostaglandin-Endoperoxide SynthasesMajor topic
PyrazolesMajor topic
Radiation-Sensitizing AgentsMajor topic
Sarcoma, ExperimentalMajor topic
SulfonamidesMajor topic
Animals
Cyclooxygenase 2
Cyclooxygenase 2 Inhibitors
Gamma Rays
Mice
Neovascularization, Pathologic
Benzenesulfonamides

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in10675387Re: Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme.https://conductscience.org/library/papers/10675387

Source PubMed

Download CSV of comments and corrections

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 195 citations.

PMIDTitleJournalYearIn PapersSource
39886153Repurposing radiosensitising medicines for radiotherapy: an overview.BMJ Oncol2024https://conductscience.org/library/papers/39886153PubMed
32720598203/212Pb Theranostic Radiopharmaceuticals for Image-guided Radionuclide Therapy for Cancer.Curr Med Chem2020https://conductscience.org/library/papers/32720598PubMed
27104573Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy-A Hypothesis-Driven Review.Antioxidants (Basel)2016https://conductscience.org/library/papers/27104573PubMed
26823679Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent.Ecancermedicalscience2016https://conductscience.org/library/papers/26823679PubMed
25371868An observational study on the expression of cyclooxygenase-2 in meningioma.Adv Biomed Res2014https://conductscience.org/library/papers/25371868PubMed
25126707Metabolic phenotyping reveals a lipid mediator response to ionizing radiation.J Proteome Res2014https://conductscience.org/library/papers/25126707PubMed
23289871Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model.BMC Urol2013https://conductscience.org/library/papers/23289871PubMed
21876693Targeting the tumor microenvironment: focus on angiogenesis.J Oncol2012https://conductscience.org/library/papers/21876693PubMed
21532508Preoperative taxane-based chemotherapy and celecoxib for carcinoma of the esophagus and gastroesophageal junction: results of a phase 2 trial.J Thorac Oncol2011https://conductscience.org/library/papers/21532508PubMed
20599771Targeting inflammatory pathways for tumor radiosensitization.Biochem Pharmacol2010https://conductscience.org/library/papers/20599771PubMed
19340516Neoplasms escape selective COX-2 inhibition in an animal model of breast cancer.Ir J Med Sci2009https://conductscience.org/library/papers/19340516PubMed
19252746COX-2 Inhibition Combined with Radiation Reduces Orthotopic Glioma Outgrowth by Targeting the Tumor Vasculature.Transl Oncol2009https://conductscience.org/library/papers/19252746PubMed
19000324Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2.J Exp Clin Cancer Res2008https://conductscience.org/library/papers/19000324PubMed
18698028Multimodality therapy: potentiation of high linear energy transfer radiation with paclitaxel for the treatment of disseminated peritoneal disease.Clin Cancer Res2008https://conductscience.org/library/papers/18698028PubMed
18392637The role of COX-2 in rectal cancer treated with preoperative radiotherapy.Virchows Arch2008https://conductscience.org/library/papers/18392637PubMed
17603773Cyclooxygenase-2 expression in human irradiated uveal melanomas.Int Ophthalmol2008https://conductscience.org/library/papers/17603773PubMed
17511025Cyclooxygenase-2 expression after preoperative chemoradiotherapy correlates with more frequent esophageal cancer recurrence.World J Gastroenterol2007https://conductscience.org/library/papers/17511025PubMed
17461495Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells.World J Gastroenterol2007https://conductscience.org/library/papers/17461495PubMed
17428102Cyclo-oxygenase-2 and its inhibition in cancer: is there a role?Drugs2007https://conductscience.org/library/papers/17428102PubMed
17293237Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice.Int J Radiat Oncol Biol Phys2007https://conductscience.org/library/papers/17293237PubMed

See all 32 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PTGS25743PubTator's text mininghttps://conductscience.org/library/genes/5743

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10469752

GET https://conductscience.org/api/papers/v1/10469752/cited_by?page=2